Viewing Study NCT06762769


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-05-12 @ 5:55 PM
Study NCT ID: NCT06762769
Status: RECRUITING
Last Update Posted: 2025-08-01
First Post: 2024-12-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Sponsor:
Organization: